Related Experiment Video
Updated: Feb 19, 2026

12:20
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
22.0K
Opioid Use by Patients After Rhinoplasty
Sagar Patel1, Angela Sturm1,2, Michael Bobian3
1Facial Plastic Surgery Associates, Houston, Texas.
JAMA Facial Plastic Surgery
|November 10, 2017
Summary
Patients undergoing rhinoplasty used significantly fewer opioid pain pills than prescribed, suggesting a need for optimized post-surgical pain management to prevent opioid misuse.
Area of Science:
- Plastic Surgery
- Pain Management
- Opioid Prescribing Practices
Background:
- Rising rates of opioid addiction and overdose in the US necessitate careful consideration of opioid use post-outpatient surgery.
- Understanding patient opioid consumption after rhinoplasty is crucial for developing safer pain management strategies.
Purpose of the Study:
- To evaluate opioid utilization patterns in patients following rhinoplasty.
- To establish an evidence-based, optimal pain management regimen for post-rhinoplasty care.
Main Methods:
- A case series analysis of 62 patients who underwent rhinoplasty between February and September 2016.
- Self-reported consumption of hydrocodone-acetaminophen tablets was compared with demographic and surgical factors.
Main Results:
- Patients used a mean of 8.7 out of 20-30 prescribed opioid tablets (40% utilization).
- 74% of patients consumed 15 or fewer tablets, with only 5% requiring refills.
- Common side effects included drowsiness (35%) and nausea (11%).
Conclusions:
- Rhinoplasty patients consume fewer opioids than prescribed, indicating potential for overprescribing.
- Implementing a multifaceted pain management program can balance effective pain control with reduced opioid diversion risk.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.1K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.1K
Analgesia and Pain Management
2.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.1K
Epistaxis
609
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
609
Opioid Receptors: Overview
4.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.9K
Parenteral Anesthetics: Overview
785
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
785

